AstraZeneca Pharma India Limited Stock NSE India S.E.
Equities
ASTRAZEN
INE203A01020
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5,335 INR | -3.95% | +1.74% | -3.46% |
Sales 2022 | 8.06B 96.47M | Sales 2023 | 10.03B 120M | Capitalization | 81.18B 972M |
---|---|---|---|---|---|
Net income 2022 | 616M 7.38M | Net income 2023 | 993M 11.89M | EV / Sales 2022 | 7.38 x |
Net cash position 2022 | 4.4B 52.66M | Net cash position 2023 | 4.93B 59.05M | EV / Sales 2023 | 7.6 x |
P/E ratio 2022 |
104
x | P/E ratio 2023 |
81.8
x | Employees | - |
Yield 2022 |
0.39% | Yield 2023 |
0.49% | Free-Float | 12.42% |
1 day | -3.95% | ||
1 week | +1.74% | ||
Current month | +0.13% | ||
1 month | +0.13% | ||
3 months | -15.57% | ||
6 months | +13.20% | ||
Current year | -3.46% |
Managers | Title | Age | Since |
---|---|---|---|
Siva Padmanabhan
CEO | Chief Executive Officer | - | - |
Sanjeev Panchal
CEO | Chief Executive Officer | - | 03-01-31 |
Bhavana Agrawal
DFI | Director of Finance/CFO | - | 23-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Revathy Ashok
BRD | Director/Board Member | 65 | 16-12-01 |
Chairman | 67 | 12-12-05 | |
Director/Board Member | 50 | 21-12-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 5,335 | -3.95% | 65,392 |
24-04-29 | 5,555 | +2.38% | 17,274 |
24-04-26 | 5,426 | +1.75% | 11,479 |
24-04-25 | 5,332 | +0.90% | 3,817 |
24-04-24 | 5,285 | +0.75% | 2,128 |
Delayed Quote NSE India S.E., April 30, 2024 at 07:42 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+33.08% | 704B | |
+28.59% | 577B | |
-3.71% | 348B | |
+18.36% | 327B | |
+4.97% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.02% | 147B |
- Stock Market
- Equities
- ASTRAZEN Stock
- ASTRAZEN Stock